Miami, FL, November 12, 2011 --(PR.com
)-- Matrixx is a leading producer of over-the-counter cold remedy and allergy products marketed under the Zicam® brand. Matrixx has a history of developing innovative products with unique delivery systems. The Company has a broad distribution platform with a presence in drug, food, mass retailers and warehouse clubs across the U.S. Zicam® is currently one of the leading brands in the cold/cough market, having grown significantly over the past decade.
Fraser Preston of HIG commented, “Matrixx should benefit from the strong product pipeline currently in development. The Zicam® brand has a significant share of the $4.5 billion cold/cough market and we plan to pursue several attractive growth opportunities in the coming years.”
HIG Capital is a leading global private equity investment firm based in Miami. The firm has more than $8.5 billion of capital under management. HIG specializes in providing capital to small and medium sized businesses and has offices in Atlanta, Boston, New York and San Francisco, as well as Hamburg, London and Paris in Europe.